Skip to main content
. 2018 Aug 6;138(5):472–482. doi: 10.1111/acps.12945

Table 2.

DIGS Mood and Other Diagnoses, Clinical Mood and other Diagnoses & Medication‐Class and Vote of Classifier Algorithm. Shaded cases were scanned on the same medication‐class as that to achieve euthymia; thus, unshaded cases held higher test validity of the classification algorithm

ID Age Sex DIGS Mood Dx Chart Mood Dx on Entry Other Chart Dx's on Entry Rx at Scan Rx of Responsea Days between scan and final chart review BD (%) MDD (%) Voting Results
1308 22 M BD‐I MDD MJ dependence; PTSD AD AP 212 63.2 36.8 BD
1310 20 M BD‐I MDD MJ dependence; PTSD AD AD 1631 16.4 83.6 MDD
1322 24 M MDD MDD Panic d/o None MS,AP 153 64.9 35.1 BD
1325 18 F None n.a. n.a. None n.a. n.a. 5.6 94.4 MDD
1349b 21 M BD‐I BD‐I Alcohol dependence MS MS,AP 1348 32.9 67.1 MDD
1364 19 F MDD MDD vs. BD None MS MS 1025 63.6 36.4 BD
1368 19 M MDD MDD vs. BD None MS MS 288 61.2 38.8 BD
1372 19 M BD‐II Nonec Alcohol dependence; MJ dependence None None 184 23.2 76.8 MDD
1378 26 M MDD MDD vs. BD None AD None 275 45 55 MDD
1392 19 F BD‐II MDD vs. BD MJ dependence; PTSD MS,AD MS 667 56.4 43.6 BD
1395 19 F MDD MDD vs. BD MJ dependence; PTSD None None 532 28 72 MDD
1407 19 M BD‐II MDD vs. BD MJ dependence; PTSD AD AD 377 17.4 82.6 MDD

Rx, medication; DIGS, Diagnostic Interview for Genetic Studies; Dx, diagnosis; d/o, disorder; PTSD, Posttraumatic Stress Disorder; MJ, Marijuana; AD, antidepressant; MS, mood stabilizer; AP, antipsychotic; n.a., not applicable.

a

The class of medication that was effective at the time the patient was stable, at the last time of evaluation as determined clinically and by chart review, to include only ADs, MSs, or APs.

b

This patient was ultimately diagnosed with schizoaffective disorder due to persistent paranoid ideation.

c

This patient was ultimately diagnosed with ADHD and GAD, but no mood disorder.